Claris Lifesciences posts revenue growth of 25 per cent for quarter ended December 31, 2014
EBITDA grew by 95 per cent
Author
Glenmark’s consolidated revenue increases to Rs 17,013.07 million for Q3 FY 14 – 15
Consolidated net profit was at Rs 1,147.60 million
Zydus completes Phase I studies for its oral HIF inhibitor
The multiple dosing studies are expected to be completed by Q2 2015
Sun Pharma posts Q3 results, maintains strong profitability
In Q3FY15, the net sales / income from operations was at Rs 4,280 crores
Signet partners with Galactic
Partnership will help its customers respond to the growing needs of the pharmaceutical industry for safe and cost-effective…
Suven Life Sciences secures product patents from Australia, Canada, Japan and New Zealand
The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being developed as…
Pfizer’s revenue increases by 16 per cent for third quarter
Sees 14 per cent increase in revenue for the nine months ended December 31, 2014
ABLE-DBT pre budget wish list
Aim to spur sluggish growth of biotech sector
Express Pharma (Vol.10, No.8) February 16-28, 2015
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the…
Jubilant Pharma appoints GP Singh as CEO
Jubilant Life Sciences Limited (JLL) has appointed Gurpartap Singh Sachdeva (Singh) as the Chief Executive Officer (CEO)